Quantcast
Last updated on April 16, 2014 at 8:29 EDT

Latest Chenodeoxycholic acid Stories

2013-09-03 16:23:59

DUBLIN, September 3, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/5zrnjs/chenodeoxycholic) has announced the addition of the "Chenodeoxycholic Acid (CAS 474-25-9) Market Research Report 2013" [http://www.researchandmarkets.com/research/5zrnjs/chenodeoxycholic ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Chenodeoxycholic Acid (CAS 474-25-9) Market Research Report 2013 presents...

2011-03-31 22:49:19

International study shows substantial efficacy of Obeticholic Acid as a treatment option Results from an international study presented today at the International Liver Congress have shown Obeticholic Acid (OCA) is a safe and effective treatment in patients suffering from Primary Biliary Cirrhosis (PBC) as demonstrated by substantial decreases in the levels of alkaline phosphatase (AP) enzyme in the blood, a key marker for PBC. In this double blind parallel group study, 59 patients received 10...

2010-01-25 07:00:00

NEW YORK, Jan. 25 /PRNewswire/ -- Intercept Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing novel therapeutics for chronic fibrotic and metabolic diseases, today announced the completion of a $25 million Preferred Series B financing by its majority shareholder Genextra S.p.A. Dr. Mark Pruzanski, founder, President and CEO commented, "This financing is recognition of the success we have had advancing our lead compounds INT-747 and INT-777. Genextra's strong...